Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 12, 2005 - Issue 4
231
Views
26
CrossRef citations to date
0
Altmetric
Original

Biochemical characteristics of variant transthyretins causing hereditary leptomeningeal amyloidosis

, , , , , , , & show all
Pages 216-225 | Published online: 06 Jul 2009
 

Abstract

Transthyretin (TTR) is a tetrameric protein that can dissociate into amyloidogenic monomers and cause TTR-related amyloidosis. A rare phenotype, called hereditary leptomeningeal TTR amyloidosis, in which TTR amyloid deposition occurs mainly in leptomeninges and subarachnoid vessels, has been reported in patients with several different TTR variants. In the present study, we examined TTR variants immunoprecipitated from the serum and cerebrospinal fluid (CSF) of patients with hereditary leptomeningeal TTR amyloidosis using matrix-assisted laser desorption ionization/time-of-flight mass spectrometry (IP-Mass method). The leptomeningeal-type TTR variants were not detected in the serum but were found at low levels in the CSF. The undetectable levels of the leptomeningeal-type TTR variants in serum could explain the minute amounts of systemic deposition of these variants. The relatively high level of unstable TTR variants in CSF, probably due to increased secretion from the choroid plexus, is considered to be the pathogenesis of the leptomeningeal-type of TTR amyloidosis.

Abbreviations
TTR=

transthyretin

FAP=

familial amyloid polyneuropathy

CSF=

cerebrospinal fluid

IP=

immunoprecipitation

MALDI/TOF MS=

matrix-assisted laser desorption ionization/time-of-flight mass spectrometry

IEF=

isoelectric focusing

2-DE=

Two-dimensional gel electrophoresis

Abbreviations
TTR=

transthyretin

FAP=

familial amyloid polyneuropathy

CSF=

cerebrospinal fluid

IP=

immunoprecipitation

MALDI/TOF MS=

matrix-assisted laser desorption ionization/time-of-flight mass spectrometry

IEF=

isoelectric focusing

2-DE=

Two-dimensional gel electrophoresis

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.